UroGen Pharma Ltd (NASDAQ: URGN) Has Another Chance To Impress You
Currently, there are 46.10M common shares owned by the public and among those 39.62M shares have been available to trade. The company’s stock has a 5-day price change of 63.23% and 8.67% over the past three months. URGN shares are trading 12.96% year to date (YTD), with the 12-month market performance down to -8.10% lower. […]
Tomorrow Is Not Likely To Be Same For UroGen Pharma Ltd (URGN)
UroGen Pharma Ltd (URGN) concluded trading on Wednesday at a closing price of $4.17, with 9.68 million shares of worth about $40.37 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.73% during that period and on May 21, 2025 the price saw a […]
Now Is A Suitable Moment For A Long-Term Purchase Of UroGen Pharma Ltd (NASDAQ: URGN)
Currently, there are 30.81M common shares owned by the public and among those 26.83M shares have been available to trade. Insiders at the company have transacted a total of 3 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 2 of these insider trades were purchases, […]